why choose us

First received: May 15, 2023

Clinical Trial: Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: COVID-19, SARS-CoV-2

Study Type: INTERVENTIONAL


Official Title: A Phase I Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3152 in Healthy Japanese Adults

Brief Summary: AZD3152 is being evaluated for administration to prevent COVID-19.This Phase I study will gather important information on the safety and tolerability of AZD3152 as well as relevant data on the PK, PD (as the neutralising responses against SARS-CoV-2) profile and the generation of ADA to AZD3152.

Read more